Prophylaxis of infection in patients with neutropenia: Guidelines of the working party on infections in haematology and oncology;Infektionsprophylaxe bei neutropenischen patienten: Leitlinien der arbeitsgemeinschaft infektionen in der hämatologie und onkologie

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 51-52, 2000, Pages 1582-1588

  Kern, W V ^a   Beyer, J ^a   Bohme A ^a   Buchheidt, D ^a   Cornely, O ^a   Einsele, H ^a   Kisro, J ^a   Kruger W ^a   Maschmeyer, G ^a   Ruhnke, M ^a   Schmidt, C A ^a   Schwartz, S ^a   Szelenyi, H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE; LEVOFLOXACIN; NYSTATIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

BACTERIAL INFECTION; CONFERENCE PAPER; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; NEUTROPENIA; PNEUMOCYSTIS CARINII; PNEUMONIA; PRACTICE GUIDELINE; RISK FACTOR; TUBERCULOSIS; VIRUS INFECTION;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HUMANS; MYCOSES; NEOPLASMS; NEUTROPENIA; QUALITY ASSURANCE, HEALTH CARE; VIRUS DISEASES;

EID: 0034704233     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9552     Document Type: Conference Paper

References (44)

1. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomized double blind, placebo controlled trial
2. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients
3. Acyclovir given as prophylaxis against oral ulcers in acute myloid leukemia: Randomized, double-blind, placebo-controlled trial
4. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myloid leukemia: A randomized, double-blind, placebo-controlled trial
5. Antimicrobial prophylaxis for infection in neutropenic patients
6. Infection risk and cancer chemotherapy: The impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignacies
7. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis
8. Guidelines for good practice in central venous catheterization
9. Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis
10. Prophylaxis of herpes infections after bone marrow transplantation by acyclovir
11. Meta-analysis of prophylactic or empirical antifugal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia
12. Catheter-related complications of cancer therapy
13. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients
14. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: Randomized double-blind trial
15. Current approaches to the prevention of catheter-related infections
16. Epidemiology of fluoroquinolone-resistant Escherichia coli among neutropenic patients
17. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for harmatological malignancies
18. Perioperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: A randomized, controlled study
19. Antifungal prophylaxis during neutropenia and immunodeficiency
20. Tuberculosis in bone marrow transplant recipients: Report of two cases and review of the literature
21. Itraconazole oral solution as prophylaxis for fungal infection in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind multicenter trial
22. Fluoroquinolone prophylaxis for the prevention of bacterial infection in patients with cancer - Is it justified?
23. A double-blind randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients
24. A randomized controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children
25. The prophylactic use of low-dose amphothericin B in bone marrow transplant patients
26. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy
27. Mycobacterial infections following bone marrow transplantation: A 20 year retrospective review
28. Antimykotische Prophylaxe bei neutropenischen und immunsupprimierten Patienten
29. Allogeneic bone marrow transplantation without protective isolation in adults with malignant disease
30. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study
31. Acyclovir prophylaxis of herpes-simplex-virus infection
32. Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: Results of a prospective, randomized, multicenter trial
33. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients
34. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A prospective, randomized, double-blind study
35. Antifungal prophylaxis in patients with hematologic malignancies: A reappraisal
36. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients
37. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: A prospective study with short-course vancomycin prophylaxis
38. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
39. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
40. Prevention of invasive fungal infections in patients with neoplastic disease
41. Invasive aspergillosis in severely neutropenic patients over 18 years: Impact of intranasal amphotericin B and HEPA filtration
42. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: A review and recommendations
43. Antimicrobial prophylaxis in the neutropenic host: Lessons of the past and perspectives for the future
44. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial